wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37487754-5735EE43-3F0C-4A92-BB6B-07A86EF10FD2
Q37487754-5735EE43-3F0C-4A92-BB6B-07A86EF10FD2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37487754-5735EE43-3F0C-4A92-BB6B-07A86EF10FD2
Targeting angiogenesis: a novel, rational therapeutic approach for non-Hodgkin lymphoma.
P2860
Q37487754-5735EE43-3F0C-4A92-BB6B-07A86EF10FD2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37487754-5735EE43-3F0C-4A92-BB6B-07A86EF10FD2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ef7c62f4e4ca0d9f50808880086ebf9d3f16f98
P2860
A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108.